Long-Term Evaluation of Tamsulosin in Benign Prostatic Hyperplasia: Placebo-Controlled, Double-Blind Extension of Phase III Trial
Open Access
- 1 June 1998
- Vol. 51 (6) , 901-906
- https://doi.org/10.1016/s0090-4295(98)00127-7
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Use of recombinant α1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophyPublished by Elsevier ,2003
- Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic HyperplasiaUrology, 1998
- Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: pharmacodynamic effectClinical Therapeutics, 1997
- Localization of the alpha 1A-Adrenoceptor in the Human ProstateJournal of Urology, 1995
- Tamsulosin, a selective α1c‐adrenoceptor* antagonist: a randomized, controlled trial in patients with benign prostatic ‘obstruction’ (symptomatic BPH)British Journal of Urology, 1995
- α1-Adrenoceptor classification: sharpening Occam's razorTrends in Pharmacological Sciences, 1994